Salem Erode Investments Limited has successfully concluded its board meeting on March 24, 2026, approving a rights issue for ₹2,293.11 lakhs. The board superseded its earlier approval from April 04, 2025, and granted fresh authorization for the fund-raising initiative under the simplified SEBI regulatory framework.

Board Meeting Outcome

The board meeting, held from 4:00 PM to 5:45 PM on March 24, 2026, approved the issuance of fully paid-up equity shares with a face value of ₹1/- each through a rights issue to eligible equity shareholders. The company filed the outcome under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Share Issue Committee Formation

The board constituted a Share Issue Committee to determine specific terms of the rights issue, including issue price, rights entitlement ratio, record date, timing, and payment terms. The committee comprises four members:

Regulatory Compliance Framework

The rights issue approval aligns with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, along with relevant SEBI circulars. The company emphasized that this represents fresh approval for the same issuance previously approved, not a new or additional equity share offering. The issuance will be conducted subject to necessary regulatory and statutory approvals under applicable laws including the Companies Act, 2013.

Issue Structure and Timeline

The rights issue will be offered to eligible equity shareholders as on the record date, which will be determined and notified subsequently. The Share Issue Committee will finalize detailed terms including the rights entitlement ratio, issue price, and payment schedule in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Company Background

Salem Erode Investments Limited operates as a subsidiary of ICL Fincorp Ltd, with its registered office in Chennai, Tamil Nadu, and corporate office in Thrissur, Kerala. The company maintains transparency through regular disclosures on its website at www.salemerode.com and continues to comply with all listing obligations under SEBI regulations. Company Secretary Visakh T. V. signed the regulatory filing confirming the board meeting outcome.

Salem erode investments Limited has announced the allotment of unlisted secured redeemable non-convertible debentures worth Rs 65,00,000 on a private placement basis. The decision was approved during the company's Debenture and Bond Committee meeting held on February 09, 2026.

Debenture Allotment Details

The committee approved the issuance of 6500 unlisted secured redeemable non-convertible debentures, each carrying a face value of Rs 1,000. The debentures were allotted on a private placement basis, representing a significant fundraising initiative by the company.

Regulatory Compliance

The company informed BSE Limited about this corporate action in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The formal communication was sent to BSE Limited's P. J. Tower office in Mumbai, ensuring proper regulatory disclosure.

Committee Authorization

The Debenture and Bond Committee of the Board of Directors exercised its authority to approve this allotment during its meeting on February 09, 2026. Company Secretary Visakh T V, holding membership number A53607, signed the regulatory filing on behalf of Salem Erode Investments Limited.

This debenture allotment represents the company's efforts to raise funds through debt instruments while maintaining compliance with applicable securities regulations and disclosure requirements.